MBX - CIK 0001776111
MBX Biosciences, Inc. has filed 198 documents with the SEC between 2019 and 2026. The most frequent type is insider trade (58 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-05-13 | - |
| Insider sale notice | 144 | 2026-05-11 | - |
| Insider trade | 4 | 2026-05-11 | 2026-05-08 |
| Major company event | 8-K | 2026-05-11 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 | - |
| Insider sale notice | 144 | 2026-05-08 | - |
| Proxy materials | DEFA14A | 2026-05-08 | - |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Insider sale notice | 144 | 2026-05-07 | - |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Insider sale notice | 144 | 2026-05-06 | - |
| Insider sale notice | 144 | 2026-05-06 | - |
| SCHEDULE 13G | - | 2026-05-06 | - |
| Insider trade | 4 | 2026-05-04 | 2026-05-01 |
| Insider sale notice | 144 | 2026-05-01 | - |
| SCHEDULE 13G/A | - | 2026-04-27 | - |
| Insider sale notice | 144 | 2026-04-22 | - |
| Annual report to shareholders | ARS | 2026-04-22 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-22 | - |
| Proxy statement | DEF 14A | 2026-04-22 | 2026-04-22 |
| Insider trade (amended) | 4/A | 2026-04-22 | 2025-11-22 |
| Insider trade (amended) | 4/A | 2026-04-22 | 2025-11-06 |
| Insider sale notice | 144 | 2026-03-25 | - |
| New insider ownership | 3 | 2026-03-18 | 2026-03-16 |
| Insider sale notice | 144 | 2026-03-16 | - |
| Insider trade | 4 | 2026-03-16 | 2026-03-13 |
| S-3ASR | - | 2026-03-12 | - |
| Employee stock plan | S-8 | 2026-03-12 | - |
| Annual report | 10-K | 2026-03-12 | 2025-12-31 |
| Major company event | 8-K | 2026-03-12 | 2026-03-12 |
| Major company event | 8-K | 2026-03-09 | 2026-03-09 |
| Insider trade | 4 | 2026-02-27 | 2026-02-26 |
| Major company event | 8-K | 2026-02-27 | 2026-02-24 |
| SCHEDULE 13D/A | - | 2026-02-11 | - |
| SCHEDULE 13G/A | - | 2026-02-10 | - |
| Major company event | 8-K | 2026-02-05 | 2026-02-04 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-01-22 | 2026-01-20 |
| New insider ownership | 3 | 2026-01-22 | 2026-01-20 |
| Major company event | 8-K | 2026-01-22 | 2026-01-20 |
| SCHEDULE 13G | - | 2026-01-21 | - |
| Insider sale notice | 144 | 2026-01-12 | - |
| Major company event | 8-K | 2026-01-12 | 2026-01-11 |
| EFFECT | - | 2025-12-08 | - |
| Company correspondence | CORRESP | 2025-12-04 | - |
| Insider trade | 4 | 2025-11-25 | 2025-11-22 |